SyloSpace

What is a lung nodule and when does it need surgery?

A lung nodule is a small spot in the lung that is usually benign, but about one in five turn out to be cancer, so care is matched to estimated risk.

Updated 48 minutes ago4 min readVersion 2
CommentsFollow

Covers: This page explains what a lung nodule is, how it is found and evaluated, and the factors that determine whether surgery or another intervention is needed. It does not cover the details of specific surgical techniques or treatment of confirmed lung cancer beyond the decision to operate.

Also answers: What is a lung nodule? · Lung nodule surgery criteria · Are lung nodules cancer? · Pulmonary nodule when to operate

person sitting while using laptop computer and green stethoscope near
Photo: National Cancer Institute

Before you read, make a guess

Fill in the blank: ?% of chest X-rays where nodules are found incidentally

Drag the slider to fill in the blank

0%50%100%

The short answer

Evidence-backed AI-prepared starting map

A lung nodule (pulmonary nodule) is a relatively small focal density in the lung; a solitary pulmonary nodule is a mass smaller than three centimeters in diameter, and a micronodule is under three millimeters. Nodules are often found incidentally — in up to 0.2% of chest X-rays and around 1% of CT scans. Most are benign (for example granulomas or hamartomas), but roughly 20% represent malignant cancer, especially in older adults and smokers. Surgery is not the first step for most nodules: management is matched to estimated risk, with CT surveillance for low-risk nodules, PET-CT and/or biopsy for intermediate-risk nodules, and surgical resection reserved for selected high-risk nodules.12

What this rests on5 independent sources
  • Evidence 23

Did this answer your question?

Be the first to vote
Your perspective belongs in the picture.Join free to vote

In brief

  1. A lung nodule is a small focal density in the lung; a solitary nodule is under three centimeters, and a micronodule is under three millimeters.1

    Evidence-backed
    Join free to vote
  2. Most nodules are benign, but around 20% represent malignant cancer, especially in older adults and smokers.1

    Evidence-backed
    Join free to vote
  3. Surgery is reserved for selected high-risk nodules; low-risk nodules are usually followed with CT surveillance and intermediate-risk nodules with PET-CT and/or biopsy.2

    Evidence-backed
    Join free to vote
  4. Comparing a nodule with previous imaging, and knowing whether it is solid or subsolid, are central to judging risk.2

    Evidence-backed
    Join free to vote
  5. The goal of management is to diagnose cancer promptly while avoiding unnecessary invasive procedures in people with benign disease.2

    Evidence-backed
    Join free to vote

At a glance

The picture in numbers

Live · updated just now

Incidental finding rate on chest X-rays

0.2%

about 1 in every 500

of chest X-rays where nodules are found incidentally1
Incidental finding rate on CT scans

1%

about 1 in every 100

of CT scans where nodules are found incidentally1
General reference figure, not broken down by nodule type

20%

20 in every 100

of nodules that represent malignant cancer1

The evidence behind it

5 sources
  • Reviews of many studies1
  • Other studies and data2
  • Background2

Published in 2026

Sources on this page by kind and year
SourceKindYear
Pulmonary Nodules.Other studies and data2026
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.Reviews of many studies2026
Lung nodule (Wikipedia)BackgroundUnknown
Pope Leo to have surgery after lump found on lungBackground2026
ACR Appropriateness Criteria® Indolent Lung Cancer.Other studies and data2026

The community around it

No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.

What it means for you

Which fits you?

Pick the situation closest to yours. Each answer says what it rests on.

If a nodule is solid and has been stable for two years

it is considered benign, so surgery is generally not needed on that basis.2

Evidence-backed

If a nodule is subsolid

it needs a longer period of stability than a solid nodule before it is considered benign, and it carries a higher risk of malignancy, especially if a solid component develops or enlarges.2

Evidence-backed

If the nodule is judged low risk

CT surveillance is the indicated approach.2

Evidence-backed

If the nodule is judged intermediate risk

PET-CT, biopsy, or both are indicated.2

Evidence-backed

If the nodule is judged high risk and selected for resection

surgical resection is the management option described.2

Evidence-backed

If you have a history of smoking or the nodule is growing

the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection.1

Evidence-backed

If your clinical team has decided to delay intervention

imaging surveillance follows separate evidence-based guidance, and a diagnostic workup or biopsy would be considered part of treatment rather than surveillance.4

Evidence-backed

The full story · 3 chapters

01

What a lung nodule is and how it is found

AI summary:A lung nodule is a small focal density in the lung, often found incidentally on chest X-rays or CT scans, and most are benign.

Evidence-backed

Evidence-backed: A lung nodule, or pulmonary nodule, is a relatively small focal density in the lung. A solitary pulmonary nodule (sometimes called a coin lesion) is a mass in the lung smaller than three centimeters in diameter; a pulmonary micronodule is less than three millimeters across. There may also be multiple nodules. One or more nodules can be an incidental finding, appearing in up to 0.2% of chest X-rays and around 1% of CT scans.1

Evidence-backed

Evidence-backed: Incidental detection is increasing as imaging techniques improve and CT scans are used more widely for thoracic evaluation. Most incidental pulmonary nodules are benign, but some represent early-stage lung cancer, which is why telling benign from malignant nodules apart is central to improving lung cancer outcomes.3

Evidence-backed

Evidence-backed: The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way.1

02

How the risk that a nodule is cancer is assessed

AI summary:Risk of cancer is judged by comparing with previous imaging, watching for growth, and noting whether the nodule is solid or subsolid.

Evidence-backed

Evidence-backed: Comparing current imaging with previous studies, when available, is essential to assess the risk of a nodule being malignant. Solid nodules that have been stable for two years are considered benign, whereas subsolid nodules need a longer period of stability before they are considered benign. Prediction models that stratify the risk of malignancy can be used to guide management of solid nodules.2

Evidence-backed

Evidence-backed: Subsolid nodules are often slower growing than solid nodules but carry a higher risk of being malignant, especially if a solid component develops or progressively enlarges.2

Evidence-backed

Evidence-backed: A history of smoking, or a nodule that is growing, may mean the possibility of cancer needs to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.1

03

When surgery is considered

AI summary:Management is matched to risk: CT surveillance for low risk, PET-CT or biopsy for intermediate risk, and surgery for selected high-risk nodules.

Evidence-backed

Evidence-backed: Management is matched to estimated risk. CT surveillance is indicated for low-risk nodules; PET-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in people who have cancer against avoiding unnecessary invasive procedures in people who have benign disease.2

Evidence-backed

Evidence-backed: Current management guidelines differ by nodule type and involve biopsy to determine whether a nodule is malignant.3

Evidence-backed

Evidence-backed: When a clinical team decides that treatment is necessary, a diagnostic imaging workup and a biopsy are typically indicated and should not be considered part of surveillance. Separate evidence-based guidance exists for imaging surveillance of indolent nodules in patients whose team has chosen to delay intervention.4

Evidence-backed

Evidence-backed: A recent news example illustrates the early-detection framing: a 71-year-old pontiff was reported to be having surgery after a nodule was found on his lung, which he said was identified "at a very early stage." This is a single reported case and does not by itself indicate when surgery is appropriate.5

Your turn

Have your say

See where others stand. Join free to add your perspective. One answer per account.

How do you feel about this?

No votes yet
Your perspective belongs in the picture.Join free to vote

Quick questions from connected pages

Before you go

What to remember

Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.

  1. Most nodules are benign, but around represent malignant cancer, especially in older adults and smokers.

  2. A lung nodule is a small focal density in the lung; a solitary nodule is under three centimeters, and a micronodule is under three millimeters.

  3. Surgery is reserved for selected high-risk nodules; low-risk nodules are usually followed with CT surveillance and intermediate-risk nodules with PET-CT and/or biopsy.

This answer keeps changing

When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 48 minutes ago). Follow it to be told when that happens.

Up nextWhat is a lung nodule and how is it treated?What is a lung nodule, and how is it evaluated and treated?

Ask this Sylo

Still wondering about something?

Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.

Behind this page

Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.

Discussion

Nobody has added anything yet. If you have experience, evidence or a different view, you could be the first.

Sources

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

  1. 1
    Lung nodule (Wikipedia)
    WikipediaPublished Sep 29, 2026Checked Oct 11, 2026
    “A lung nodule or pulmonary nodule is a relatively small focal density in the lung. A solitary pulmonary nodule (SPN) or coin lesion, is a mass in the lung smaller than three centimeters in diameter. A pulmonary micronodule has a diameter of less than three millimetres. There may also be multiple nodules. One or more lung nodules can be an incidental finding found in up to 0.2% of chest X-rays and around 1% of CT scans. The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way. If the patient has a history of smoking or the nodule is growing, the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.”
  2. 2
    Pulmonary Nodules.
    The New England journal of medicine (Callister & Silvestri)Published Sep 1, 2026Checked Oct 11, 2026
    “Management strategies differ according to the type of nodule. A comparison of current and previous imaging studies, when available, is essential to assess the risk of the nodule being malignant. Solid nodules that have been stable for 2 years are considered to be benign, whereas subsolid nodules require a longer period of stability to be considered benign. Prediction models to stratify the risk of the nodule being malignant can be used to guide the management of solid nodules. Computed tomographic (CT) surveillance is indicated for low-risk nodules; positron-emission tomography-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Subsolid nodules are often slower growing than solid nodules but are associated with a higher risk of being malignant, especially if a solid component develops or progressively enlarges. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in persons who have cancer with the avoidance of unnecessary invasive procedures in persons who have benign disease.”
  3. 3
    Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.
    Lung cancer (Amsterdam, Netherlands) (Soo et al.)Published Aug 3, 2026Checked Oct 11, 2026
    “Lung cancer is the leading cause of cancer-related deaths globally, and early diagnosis and treatment are important for improving prognosis. Pulmonary nodules (PNs) are small pulmonary lesions frequently identified during clinical practice, with incidental detection increasing due to advances in imaging techniques and the expanded use of computed tomography scans for thoracic evaluation. The majority of incidental PNs (IPNs) are benign, however some represent early-stage lung cancer, therefore distinguishing benign from malignant IPNs is key to improving lung cancer outcomes. Current management guidelines differ by nodule type and involve biopsy to determine the malignancy status of the nodule. Here, we review current knowledge on the classification, prevalence, and detection of PNs, as well as the current management and risk stratification of PNs. We outline the role of oncogenic driver mutations in the pathobiology of PNs and assess current literature on targeted treatment of oncogene-driven PNs. Finally, we discuss evidence gaps and areas for future research.”
  4. 4
    ACR Appropriateness Criteria® Indolent Lung Cancer.
    Journal of the American College of Radiology : JACR (Expert et al.)Published Aug 10, 2026Checked Oct 11, 2026
    “If the team determines that treatment is necessary, a diagnostic imaging workup and a biopsy are typically indicated and should not be considered part of surveillance. Therefore, this document aims to outline evidence-based guidelines specifically for imaging surveillance of indolent pulmonary nodules in patients for whom the clinical team has chosen to delay intervention. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.”
  5. 5
    Pope Leo to have surgery after lump found on lung
    BBC NewsPublished Oct 11, 2026Checked Oct 11, 2026
    “The 71-year-old pontiff said the nodule was identified "at a very early stage".”

How it changed

Published 1 time since Oct 11, 2026.

  1. Version 2Oct 11, 2026Live now

    AI-prepared Starting Map from live research.

    • First published version.
Every version, side by side

Help improve it

The brief is open about what's uncertain. These are the specific gaps that new material would fill.

Open questions

  • What specific nodule sizes, growth rates or risk-model scores define low, intermediate and high risk in current guidelines?

    No answers yet

  • How long must a subsolid nodule remain stable before it is considered benign, and how does that compare with the two-year rule for solid nodules?

    No answers yet

  • For high-risk nodules that go to surgery, what proportion turn out to be cancer, and what are the harms of operating on benign nodules?

    No answers yet

  • What is the current evidence on targeted treatment of oncogene-driven pulmonary nodules, and where are the main gaps?

    No answers yet

Around this topic

Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.

Ask this Sylo

Answers only from “What is a lung nodule and when does it need surgery?”

Ask anything about this page. The AI reads only its reviewed brief, sources and contributions, cites what it used, and says when the page doesn't cover something.